Worldwide experts lead our team in the field of Extracorporeal Membrane Oxygenation Support. Join us!Read more
The INF-ECMO Study
Nosocomial Infections in patients treated with Extracorporeal Membrane Oxygenation
Nosocomial Infections are a common and dreadful complication for patients treated with Extracorporeal Membrane Oxygenation.
Unfortunately, no study has thoroughly evaluated NI in this fragile patient cohort.
Newly developed antibiotics may help manage such infections, but their pharmacokinetics during ECMO has not been evaluated.
Our aim is to describe incidence, microbial etiology, and resistance patterns, and assess risk factors for Nosocomial Infections in a prospective cohort of patients undergoing ECMO.
Moreover, we want to provide a pharmacokinetics analysis of ceftazidime/avibactam, meropenem/vaborbactam, ceftolozane/tazobactam, and cefiderocol in adult patients undergoing ECMO.